{
 "drug": "Spironolactone Tablet",
 "asOf": "2026-08-25",
 "status": "discontinuing",
 "since": "12/10/2025",
 "dayN": 258,
 "cat": "Cardiovascular",
 "companies": [
  "Pfizer Inc."
 ],
 "reasons": [],
 "records": [
  {
   "discontinued_date": "12/10/2025",
   "update_type": "New",
   "initial_posting_date": "12/10/2025",
   "package_ndc": "0025-1001-31",
   "generic_name": "Spironolactone Tablet",
   "contact_info": "800-533-4535",
   "related_info": "Discontinuation of the manufacture of the drug.",
   "openfda": {
    "application_number": [
     "NDA012151"
    ],
    "brand_name": [
     "ALDACTONE"
    ],
    "generic_name": [
     "SPIRONOLACTONE"
    ],
    "manufacturer_name": [
     "Pfizer Laboratories Div Pfizer Inc"
    ],
    "product_ndc": [
     "0025-1001",
     "0025-1041",
     "0025-1031"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "SPIRONOLACTONE"
    ],
    "rxcui": [
     "198222",
     "198223",
     "200817",
     "200820",
     "200825",
     "313096"
    ],
    "spl_id": [
     "22946678-dcad-4518-9bc6-cbdf51a38c16"
    ],
    "spl_set_id": [
     "0fed2822-3a03-4b64-9857-c682fcd462bc"
    ],
    "package_ndc": [
     "0025-1001-31",
     "0025-1041-31",
     "0025-1031-31"
    ],
    "nui": [
     "N0000175557",
     "N0000011310"
    ],
    "pharm_class_epc": [
     "Aldosterone Antagonist [EPC]"
    ],
    "pharm_class_moa": [
     "Aldosterone Antagonists [MoA]"
    ],
    "unii": [
     "27O7W4T232"
    ]
   },
   "update_date": "12/10/2025",
   "therapeutic_category": [
    "Cardiovascular"
   ],
   "dosage_form": "Tablet",
   "presentation": "Aldactone, Tablet, 25 mg (NDC 0025-1001-31)",
   "company_name": "Pfizer Inc.",
   "status": "To Be Discontinued"
  },
  {
   "discontinued_date": "12/10/2025",
   "update_type": "New",
   "initial_posting_date": "12/10/2025",
   "package_ndc": "0025-1031-31",
   "generic_name": "Spironolactone Tablet",
   "contact_info": "800-533-4535",
   "related_info": "Discontinuation of the manufacture of the drug.",
   "openfda": {
    "application_number": [
     "NDA012151"
    ],
    "brand_name": [
     "ALDACTONE"
    ],
    "generic_name": [
     "SPIRONOLACTONE"
    ],
    "manufacturer_name": [
     "Pfizer Laboratories Div Pfizer Inc"
    ],
    "product_ndc": [
     "0025-1031",
     "0025-1001",
     "0025-1041"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "SPIRONOLACTONE"
    ],
    "rxcui": [
     "198222",
     "198223",
     "200817",
     "200820",
     "200825",
     "313096"
    ],
    "spl_id": [
     "22946678-dcad-4518-9bc6-cbdf51a38c16"
    ],
    "spl_set_id": [
     "0fed2822-3a03-4b64-9857-c682fcd462bc"
    ],
    "package_ndc": [
     "0025-1001-31",
     "0025-1041-31",
     "0025-1031-31"
    ],
    "nui": [
     "N0000175557",
     "N0000011310"
    ],
    "pharm_class_epc": [
     "Aldosterone Antagonist [EPC]"
    ],
    "pharm_class_moa": [
     "Aldosterone Antagonists [MoA]"
    ],
    "unii": [
     "27O7W4T232"
    ]
   },
   "update_date": "12/10/2025",
   "therapeutic_category": [
    "Cardiovascular"
   ],
   "dosage_form": "Tablet",
   "presentation": "Aldactone, Tablet, 100 mg (NDC 0025-1031-31)",
   "company_name": "Pfizer Inc.",
   "status": "To Be Discontinued"
  }
 ]
}